Eligo Bioscience
eligo.bioLocations
Île-de-France, France · Paris, France · Paris, France
industry
Biotechnology · Biotechnology Research · Health Care · Medical
Size
11 - 50 employees
Stage
Pre Seed
founded in
2014
About
Eligobiotics is a developer of antibiotics intended to treat microbiome precision and bacteria-associated diseases. The company's antibiotics combine the CRISPR/Cas system with engineered phage capsids to develop antimicrobials that are used to eradicate resistant pathogens or virulent bacteria within the human microbiome, enabling clients to get next-generation antimicrobials to treat diseases caused by superbugs.
Open jobs at Eligo Bioscience
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.